Oops! Something went wrong, please try again later.
NRx Pharmaceuticals, Inc. draws upon decades of collective, scientific, and drug-development experience to address very high unmet needs of patients.
Frequently asked questions
Q:
NRx has promised its shareholders to invest their funds in the development of NRX-101 to treat CNS disorders such as bipolar depression, chronic pain, and PTSD. Isn’t this a distraction from your mission?
A:
Our commitment to life-threatening CNS disorders has not changed. By investing a small amount of exploratory capital in the laboratory work that we performed, we have unlocked a...
Save
Share
More
